Urol. praxi. 2017;18(1):34-36 | DOI: 10.36290/uro.2017.009

Five-year survival after radical nephrectomy for primary renal leiomyosarcoma

MUDr. Tereza Balajková1, MUDr. Eva Poláčková1, MUDr. Karel Zita1, MUDr. Katarína Spurná1, MUDr. Osvald Celman1, MUDr. Eva Jandáková2
1Urologické oddělení, Nemocnice Břeclav, 2Patologicko-anatomické oddělení, Nemocnice Břeclav

The authors describe the case of a patient with the tumor of the upper pole of the left kidney, incidentally detected sonographically,

which was performed in July 2011 due to a right hypogastric pain. There were no dissemination detected by imaging before

operation. Histologically, after the left-sided radical transperitoneal nephrectomy, there was confirmed leiomyosarcoma of the

kidney – low grade, no lymph nodes was positive. Even though the bad prognosis of these tumor group, the patient is right now

5 years after the nephrectomy with no detection of a local recurrence or metastases.

Keywords: leiomyosarcoma, radical nephrectomy, overall survival

Published: March 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Balajková T, Poláčková E, Zita K, Spurná K, Celman O, Jandáková E. Five-year survival after radical nephrectomy for primary renal leiomyosarcoma. Urol. praxi. 2017;18(1):34-36. doi: 10.36290/uro.2017.009.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer 2013; 49(6): 1374-1403. Go to original source... Go to PubMed...
    2. Sun M, et al. 1634 Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death tradeoffs between surgery and active surveillance. J Urol. [online] 2013; 18(4): e672 [cit. 2016-09-15]. Dostupný na www: http://www.jurology.com/article/S0022-5347(13)03376-4/fulltext. Go to original source...
    3. Srinivas V, Sogani PC, Hajdu SI, Whitmore WF, Jr. Sarcomas of the kidney. J Urol. 1984; 132(1): 13-16. Go to original source... Go to PubMed...
    4. Sharma D, Pradhan S, Aryya NC, Shukla VK. Leiomyosarcoma of kidney - a case report with long term result after radiotherapy and chemotherapy. Int Urol Nephrol. 2007; 39(2): 397-400. Go to original source... Go to PubMed...
    5. Choudhury M, Singh SK, Pujani M, Pathania OP. A case of leiomyosarcoma of kidney clinically and radiologically misdiagnosed as renal cell carcinoma. Indian J Cancer 2009; 46(3): 241-243. Go to original source... Go to PubMed...
    6. Farshid G, Goldblum J, Weiss SW. Leiomyosarcoma of soft tissue: a tumor of vascular origin with multivariate analysis of outcome. Mod Pathol. 2003; 16(8): 778-785.
    7. Gustafson P, Willen H, Baldetrop B, et al. Soft tissue leiomyosarcoma: a population-based epidemiologic and prognostic study of 48 patients, including cellular DNA content. Cancer 1992; 70(1): 114-119. Go to original source...
    8. Fletcher CDM, Cin PD, Wever I, et al. Correlation between Clinicopathological Features and Karyotype in Spindle Cell Sarcomas: A Report of 130 Cases from the CHAMP Study Group. Am J of Pathology 1999; 154(6): 1841-1847. Go to original source... Go to PubMed...
    9. Mankin HJ, Casas-Ganem J, Kim JI, et al. Leiomyosarcoma of somatic soft tissues. Clin Orthop Relat Res. 2004 Apr; (421): 225-231. Go to original source... Go to PubMed...
    10. Prošvic P, Morávek P, Veselský Z, et al. Primární leiomyosarkom ledviny - kazuistika. Ces Urol 2003; 7(4): 28-31.
    11. Moudouni SM, En-Nia I, Rioux-Leclerq N, et al. Leiomyosarcoma of the renal pelvis. Scand J Urol Nephrol. 2001; 35(5): 425-427. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.